跳至主要内容
临床试验/KCT0006797
KCT0006797已完成未知

A comparison of respiratory effects of propofol and remimazolam during procedural sedation: a randomized controlled trial.

Samsung Medical Center0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 75(Year)(—)
性别
All

入选标准

  • 1) Patients with the ASA PS class I~III
  • 2) Patients scheduled for the insertion of central venous access port devices for the delivery of chemotherapy under monitored anesthetic care(MAC)

排除标准

  • 1) Patients with severe cognitive dysfunction
  • 2) Body Mass Index > 35 kg / m 2 or <18.5 kg / m 2
  • 3) Severe liver disease
  • 4) Neuromuscular disease or mental illness kidney disease (GRF <30 or under hemodialysis)
  • 5) Those diagnosed with metabolic diseases
  • 6) Drug addiction or alcohol addiction
  • 7) People who have contraindications to benzodiazepine, sevoflurane, or propofol
  • (Patients who have allergies to drugs or have a history of hypersensitivity reactions)
  • 8) acute narrow-angle glaucoma
  • 9) intolerance to galactose, deficiency of Lapp lactase, glucose-galactose absorption disorder
  • 10) severe hypersensitivity to dextran 40

研究者

相似试验